Company Encyclopedia
View More
name
INNOGEN-B
02591.HK
Guangzhou Innogen Pharmaceutical Group Co., Ltd engages in development of drugs. Its products are used for treatment of metabolic diseases, including diabetes, obesity, and MASH; and other major central nervous system diseases. The company was incorporated in 2014 and is based in Shanghai, China.
1.296 T
02591.HKMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Top 10 HK Stock Gainers (12.10)

    INNOGEN-B(02591) rose 19.15%, with a trading turnover 231.9 Million HKD, and a year-to-date rose 105.1%. CHINA VANKE(02202) rose 13.17%, with a trading turnover 1.2 Billion HKD, and a year-to-date fell 28.5%. JACOBIO-B(01167) rose 11.42%, with a trading turnover 98.2 Million HKD, and a year-to-date rose 591.3%.

    Top Gainers & Losers·
    HK
    02591
    +19.15%
    HK
    02202
    +13.17%
    HK
    01167
    +11.42%
    Top Gainers & Losers·
    HK
    02591
    +19.15%
    HK
    02202
    +13.17%
    HK
    01167
    +11.42%

    Hong Kong stocks closed｜Three major indices closed higher! Technology and catering stocks led the rise, with Meituan up 2.72% and HAIDILAO soaring

    The Hong Kong stock market closed today with all three major indices slightly up. The Hang Seng Index and the Hang Seng Tech Index failed to break through their recent highs, with structural opportunities in the market concentrated in the internet and technology sectors. Leading companies in the restaurant and technology sectors performed prominently, while restaurant and internet growth stocks attracted capital attention. Improved consumer data continues to support market sentiment, and some small-cap stocks experienced significant fluctuations

    Market Heartbeat·
    HK
    09888
    +1.81%
    HK
    02591
    +19.15%
    HK
    02202
    +13.17%
    Market Heartbeat·
    HK
    09888
    +1.81%
    HK
    02591
    +19.15%
    HK
    02202
    +13.17%

    Hong Kong stocks intraday | All three major indices turned positive at noon! LEGEND UPSTAR surged 61% during the session, showing a clear divergence from the retail sector

    The three major indices of the Hong Kong stock market fluctuated and consolidated during the trading session, with the Hang Seng Index, Hang Seng TECH Index, and the National Enterprises Index all turning positive at midday. The market showed a divergence in hotspots, with the retail sector declining overall due to weakened consumer demand, lacking leading stocks but with significant movements in some individual stocks. On the macro level, the year-on-year retail sales increase supports consumer and service confidence, with ongoing structural opportunities. Stocks like LEGEND UPSTAR and DESIGN CAPITAL surged significantly, with capital activity focusing on mainstream blue chips and stocks hitting new highs, indicating that structural opportunities still exist in the Hong Kong stock market

    Market Heartbeat·
    HK
    09888
    +1.81%
    HK
    06869
    +10.97%
    HK
    02202
    +13.17%
    Market Heartbeat·
    HK
    09888
    +1.81%
    HK
    06869
    +10.97%
    HK
    02202
    +13.17%

    Hong Kong Stock Movement: INNOGEN-B rises 12.94%, driven by the dual benefits of inclusion in the Stock Connect and the medical insurance catalog

    INNOGEN-B rose 12.94%; Innovent Biologics fell 0.89%, with a transaction volume of HKD 522 million; CanSino Biologics fell 2.85%, with a transaction volume of HKD 431 million; BeiGene fell 1.46%, with a transaction volume of HKD 411 million; Kelun-Biotech fell 4.45%, with a market capitalization of HKD 95.1 billion

    HK Stock Movers Tracker·
    HK
    02591
    +19.15%
    HK Stock Movers Tracker·
    HK
    02591
    +19.15%

    Hong Kong Stock Mid-Review | Three major indices adjusted, YOFC led the intraday gains, with second-line sectors such as pharmaceuticals and gold active

    As of noon, the main indices of the Hong Kong stock market have collectively retreated, with the Hang Seng Index, Technology Index, and National Enterprises Index all experiencing slight declines, indicating a clear market wait-and-see sentiment. The sector differentiation pattern is prominent, with leading companies in retail, technology, and communication equipment showing mixed performance. YOFC rose against the trend, while the pharmaceutical, gold, and agricultural machinery sectors were partially active, with funds shifting towards second-tier themes. Retail sales year-on-year rose to 5.3%, improving domestic demand and boosting confidence, but the sustainability of the recovery remains to be observed. The overall market turnover is concentrated in internet and technology manufacturing giants, with some small and mid-cap stocks showing significant gains, and the market's hotspots are switching rapidly

    Market Heartbeat·
    HK
    02591
    +19.15%
    HK
    03330
    +9.36%
    HK
    00038
    +10.00%
    Market Heartbeat·
    HK
    02591
    +19.15%
    HK
    03330
    +9.36%
    HK
    00038
    +10.00%
    Posts
    View More

    $INNOGEN-B(02591.HK) Everyone draws lots...

    © 2025 Longbridge｜Disclaimer